These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8862894)

  • 61. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
    Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
    Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
    Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
    Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
    Rasty G; Murray R; Lu L; Kubilis P; Benrubi G; Masood S
    Ann Clin Lab Sci; 1998; 28(3):138-43. PubMed ID: 9646853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA replication error in endometrial carcinoma and complex atypical endometrial hyperplasia.
    Ohwada M; Suzuki M; Kashiwagi H; Konishi F; Sato I
    Cancer Genet Cytogenet; 1999 Oct; 114(2):130-5. PubMed ID: 10549270
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oncogenes, growth factors, and prognostic indicators in colorectal cancer.
    Rowley S; Newbold M; Neoptolemos JP
    Surg Annu; 1992; 24 Pt 2():59-85. PubMed ID: 1440150
    [No Abstract]   [Full Text] [Related]  

  • 67. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Significance on expressions of Annexin-I and its correlative gene proteins in endometrial hyperplasia, atypical hyperplasia and endometrial carcinoma].
    Da J; Meng X; Wang P; Yang Z; Zhu Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):256-9. PubMed ID: 11758212
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
    Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
    Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heredity and endometrial carcinoma.
    Lynch HT; Krush AJ; Larsen AL
    South Med J; 1967 Mar; 60(3):231-5. PubMed ID: 6020489
    [No Abstract]   [Full Text] [Related]  

  • 71. [A study on expression of tumor suppressor gene p53 in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):647-50. PubMed ID: 8745486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ras gene mutations in human endometrial carcinoma.
    Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
    Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
    de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
    J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endometrial intraepithelial neoplasia.
    Owings RA; Quick CM
    Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.
    Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
    Czerwenka KF; Heuss F; Zeillinger R; Hosmann JW; Wagner T; Manavi M; Jelincic D; Lu Y; Kubista E
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():287-8. PubMed ID: 7906978
    [No Abstract]   [Full Text] [Related]  

  • 77. Endometrial findings in asymptomatic postmenopausal women on exogenous estrogens--a preliminary report.
    Simsen DA; Shirts SR; Howard FM; Sims J; Hill JM
    Gynecol Oncol; 1981 Feb; 11(1):56-63. PubMed ID: 7203163
    [No Abstract]   [Full Text] [Related]  

  • 78. Genetic alterations in human prostate cancer: a review of current literature.
    Ozen M; Pathak S
    Anticancer Res; 2000; 20(3B):1905-12. PubMed ID: 10928125
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MMAC/PTEN gene expression in endometrial cancer: RT-PCR studies.
    Sobczuk A; Smolarz B; Romanowicz-Makowska H; Pertyński T
    Pol J Pathol; 2006; 57(3):137-40. PubMed ID: 17219740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of HOXA10 in endometrial hyperplasia and adenocarcinoma and regulation by sex hormones in vitro.
    Zhong G; Wang Y; Liu X
    Int J Gynecol Cancer; 2011 Jul; 21(5):800-5. PubMed ID: 21670700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.